A Study on PELGE Nanoparticles as Controlled Drug Delivery Systems for Intravenous

Abstract:

Article Preview

The objective of this study was to evaluate the in vivo characteristics of poly (ethylene glycol)-poly (lacticacid-co-glycolicacid)-poly (ethylene- glycol) (PELGE) copolymers as drug carriers. In order to test this circulation time, mitoxantrone (DHAQ) was used as a model drug in this study. DHAQ nanoparticles (DHAQ-NP) were prepared, subsequently the DHAQ-NP were evaluated by measuring the drug concentration in plasma after intravenous administration via the tail vein of mice. The circulation time of the DHAQ-NP were tested. The results showed prolonged mitoxantrone (DHAQ) residence in systemic blood circulation.

Info:

Periodical:

Key Engineering Materials (Volumes 288-289)

Edited by:

Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata

Pages:

163-166

Citation:

Y. R. Duan et al., "A Study on PELGE Nanoparticles as Controlled Drug Delivery Systems for Intravenous", Key Engineering Materials, Vols. 288-289, pp. 163-166, 2005

Online since:

June 2005

Export:

Price:

$38.00

[1] Li S. M, Vert M, in degradable polymers: principles and applications, G. Scott and D. Gilead, Eds., Chapman &Hall, London, (1995), pp.43-87.

[2] Liu, W.S. Huang, Y. Zhang, Z.R. Synthesis and Characterization of the Tumor Targeting Mitoxantrone -Insulin Conjugate. Archives of Pharmacal Research. 26 (2003), 892-897.

DOI: https://doi.org/10.1007/bf02980195

[3] Avgoustakis, K. Beletsi, A. Ithakissios, D.S. Journal of Controlled Release. 79 (2002), 123-135.

Fetching data from Crossref.
This may take some time to load.